Results for tag: "Charcot Marie Tooth Drug"

Charcot Marie Tooth (CMT) is a group of inherited neurological disorders that affect the peripheral nerves. It is the most common inherited neurological disorder, affecting approximately 1 in 2,500 people worldwide. Symptoms of CMT include muscle weakness, foot deformities, and impaired sensation in the feet and lower legs. Currently, there are no approved drugs for the treatment of CMT. However, there are several companies researching and developing potential treatments. These include pharmaceutical companies such as Pfizer, Sanofi, and Novartis, as well as biotechnology companies such as Ionis Pharmaceuticals and Audentes Therapeutics. These companies are researching a variety of treatments, including gene therapy, small molecule drugs, and monoclonal antibodies. While there is still much work to be done, the development of treatments for CMT is an important step in improving the lives of those affected by this disorder. Show Less Read more